The Efficacy and Toxicity of Adjuvant Gemcitabine-Cisplatin Chemotherapy in Patients with Advanced Bladder Cancer Underwent Radical Cystectomy

Publisher： Karger

E-ISSN： 1661-7657|4|1|25-29

ISSN： 1661-7649

Source： Current Urology, Vol.4, Iss.1, 2010-01, pp. : 25-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Adjuvant Gemcitabine-Cisplatin Chemotherapy: A Comparative Study between Locally Advanced Transitional Cell Carcinoma of the Bladder and Upper Urinary Tract

By  

Urologia Internationalis, Vol. 85, Iss. 1, 2010-03 ,pp. : 47-51

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin in Adjuvant Regimen for Bladder Cancer

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Adjuvant cisplatin‐based combined chemotherapy for lymph node (LN)‐positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 722-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 290-297

Karger

Access to resources Recommend Favorite